Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Alexion Pharmaceuticals Company Profile (NASDAQ:ALXN)

Consensus Ratings for Alexion Pharmaceuticals (NASDAQ:ALXN) (?)
Ratings Breakdown: 5 Hold Rating(s), 11 Buy Rating(s)
Consensus Rating:Buy (Score: 2.69)
Consensus Price Target: $186.29 (2.10% downside)

Analysts' Ratings History for Alexion Pharmaceuticals (NASDAQ:ALXN)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/1/2014Bank of AmericaInitiated CoverageBuy$197.00ViewTweet This Rating  Share This Rating on StockTwits
9/23/2014ZacksReiterated RatingNeutral -> Neutral$168.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014SunTrustInitiated CoverageBuy$229.00ViewTweet This Rating  Share This Rating on StockTwits
9/4/2014Credit SuisseInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
7/25/2014NomuraReiterated RatingBuy$222.00 -> $224.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014Stifel NicolausReiterated RatingBuy$220.00 -> $222.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014JPMorgan Chase & Co.Reiterated RatingOverweight$210.00 -> $220.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014Credit SuisseReiterated RatingNeutral$174.00 -> $179.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2014ZacksReiterated RatingNeutral -> Neutral$176.00ViewTweet This Rating  Share This Rating on StockTwits
5/9/2014JPMorgan Chase & Co.Reiterated RatingOverweight$200.00 -> $210.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2014Stifel NicolausReiterated RatingBuy$219.00 -> $220.00ViewTweet This Rating  Share This Rating on StockTwits
4/21/2014Ned Davis ResearchUpgradeSell -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/27/2014Credit SuisseBoost Price TargetNeutral$171.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Robert W. BairdBoost Price Target$175.00 -> $199.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Brean CapitalBoost Price Target$200.00 -> $215.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014NomuraBoost Price Target$214.00 -> $222.00ViewTweet This Rating  Share This Rating on StockTwits
3/11/2014Stifel NicolausBoost Price TargetBuy$207.00 -> $219.00ViewTweet This Rating  Share This Rating on StockTwits
3/6/2014BarclaysBoost Price TargetOutperform$181.00 -> $193.00ViewTweet This Rating  Share This Rating on StockTwits
2/10/2014Deutsche BankBoost Price TargetBuy$125.00 -> $205.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Jefferies GroupBoost Price TargetHold$106.00 -> $145.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Leerink SwannBoost Price Target$125.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Canaccord GenuityBoost Price TargetBuy$161.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014BarclaysBoost Price TargetOverweight$141.00 -> $181.00ViewTweet This Rating  Share This Rating on StockTwits
1/31/2014Stifel NicolausBoost Price TargetBuy$138.00 -> $207.00ViewTweet This Rating  Share This Rating on StockTwits
1/30/2014Brean CapitalBoost Price TargetBuy$142.00 -> $200.00ViewTweet This Rating  Share This Rating on StockTwits
1/10/2014BarclaysReiterated RatingOverweight$127.00 -> $141.00ViewTweet This Rating  Share This Rating on StockTwits
1/8/2014NomuraInitiated CoverageBuy$150.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Canaccord GenuityBoost Price TargetBuy$138.00 -> $161.00ViewTweet This Rating  Share This Rating on StockTwits
1/6/2014Goldman SachsDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
11/26/2013Piper JaffrayInitiated CoverageOverweight$172.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013OppenheimerBoost Price Target$115.00 -> $125.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Jefferies GroupBoost Price TargetHold$97.00 -> $106.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013GuggenheimBoost Price TargetBuy$127.00 -> $130.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Cowen and CompanyBoost Price TargetOutperform$115.00 -> $123.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Canaccord GenuityBoost Price TargetBuy$132.00 -> $138.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013BarclaysBoost Price TargetOverweight$121.00 -> $127.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2013Stifel NicolausBoost Price TargetBuy$131.00 -> $138.00ViewTweet This Rating  Share This Rating on StockTwits
9/18/2013Goldman SachsBoost Price TargetHold$122.00 -> $139.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013Jefferies GroupBoost Price TargetHold$88.00 -> $97.00ViewTweet This Rating  Share This Rating on StockTwits
7/26/2013BarclaysBoost Price TargetOverweight$118.00 -> $121.00ViewTweet This Rating  Share This Rating on StockTwits
7/25/2013Brean CapitalReiterated RatingBuy$120.00ViewTweet This Rating  Share This Rating on StockTwits
5/31/2013Credit SuisseInitiated CoverageNeutral$110.00ViewTweet This Rating  Share This Rating on StockTwits
4/25/2013Wells Fargo & Co.Reiterated RatingMarket PerformViewTweet This Rating  Share This Rating on StockTwits
4/22/2013Deutsche BankReiterated RatingBuy$117.00ViewTweet This Rating  Share This Rating on StockTwits
4/19/2013TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/27/2013TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
2/20/2013Lazard LtdUpgradeNeutral -> Buy$102.00ViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Robert W. BairdReiterated RatingOutperform$125.00ViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Stifel NicolausLower Price Target$125.00 -> $118.00ViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Jefferies GroupCut EstimatesHold$90.00 -> $88.00ViewTweet This Rating  Share This Rating on StockTwits
2/15/2013Bank of AmericaReiterated RatingBuy$120.00 -> $124.00ViewTweet This Rating  Share This Rating on StockTwits
1/28/2013TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/23/2013Brean CapitalReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Janney Montgomery ScottInitiated CoverageNeutral$107.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Janney Montgomery ScottInitiated CoverageNeutralViewTweet This Rating  Share This Rating on StockTwits
12/27/2012TheStreetReiterated RatingBuyViewTweet This Rating  Share This Rating on StockTwits
12/24/2012Citigroup Inc.Initiated CoverageNeutral$104.00ViewTweet This Rating  Share This Rating on StockTwits
12/13/2012Goldman SachsInitiated CoverageBuyViewTweet This Rating  Share This Rating on StockTwits
12/10/2012Robert W. BairdReiterated RatingOutperform$125.00ViewTweet This Rating  Share This Rating on StockTwits
12/7/2012Citigroup Inc.Initiated CoverageNeutral$104.00ViewTweet This Rating  Share This Rating on StockTwits
11/9/2012GuggenheimInitiated CoverageBuy$121.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/25/2012 forward)
Discuss Alexion Pharmaceuticals